A Phase II Randomized, Double-blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide with or without Deforolimus...

Printer-friendly versionSend by emailPDF version

Name

Merck and Company

Anticipated Amount

11 250.00

Activity Type

Clinical Trial

Award Type

Contract

Date

June 26, 2010 to July 15, 2010

Award Number

003157-00001

Sponsor Award Number

ck#1000021005

Award Contacts

Name

Ahmann,Frederick R

Title

Principal Investigator

Unit

Cancer Center Division

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona